← Open Payments lookup

JAIME ALMANDOZ: Open Payments

NPI 1215060876 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$194,176 in 137 payments from 10 companies in 2025. Trend: 2023 $38,818 · 2024 $66,067 · 2025 $194,176

Consulting: $100,161Travel & lodging: $71,126Speaker / faculty: $18,420Food & beverage: $3,301Honoraria: $1,071Education: $97
CompanyPaymentsAmount
Boehringer Ingelheim International GmbH37$62,069
Boehringer Ingelheim Pharmaceuticals, Inc.33$46,544
Eli Lilly and Company27$27,683
Amgen Inc.10$24,419
Novo Nordisk AS12$16,633
Novo Nordisk Inc10$8,637
ABBVIE INC.2$4,650
Lilly USA, LLC3$2,387
Rhythm Pharmaceuticals, Inc.1$1,071
Perspectum Diagnostics Ltd2$81

Products named: ZEPBOUND, MOUNJARO, Wegovy, KISUNLA, TEPEZZA.

Industry payments across TX — which companies pay providers there.